Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Alaska governor seeks Korean partners for $44 bn LNG project
Alaska Governor Mike Dunleavy arrived in South Korea on Monday to hold a series of one-on-one meetings with top executives from Korean energy and st...
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Boryung, Lotus Pharma signs CDMO deal on anticancer injection
South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...
Junior bankers choosing track records over name value
A number of junior bankers at the Korean offices of major global investment banks such as Morgan Stanely and J.P.Morgan have resigned since July wit...
Huonslab eyes speedy anticancer drug delivery with new patent
South Korean biotech Huons Global Co. said on Tuesday that its research and development unit Huonslab has issued a domestic patent claiming a techno...
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
Celltrion to export three anticancer drugs to Europe
South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...
LG Chem to start phase 3 for head, neck cancer drug in US
South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...
Celltrion, Cyron to develop multi-specific antibody new drug
South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...
Hanmi Science joins race to develop Wegovy competitor
Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...
Voronoi to strengthen AI-driven open innovation
South Korea’s biotechnology startup Voronoi Inc. announced on Monday that it is intensifying its artificial intelligence (AI)-driven new drug ...
ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug
New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...
Samsung Bioepis to enhance biosimilar presence with Epysqli
FRANKFURT – Samsung Bioepis Co., a biopharmaceutical unit of South Korea’s top conglomerate Samsung, is looking to gain ground in the ra...
SK Energy opens S.Korea's first hydrogen charging station for large trucks
SK Energy is the first company in South Korea to launch a station for charging large hydrogen-powered trucks. The company on Sunday said it held a c...
Korea to raise young chip engineers for Samsung, SK Hynix
South Korea plans to nurture more youths specialized in semiconductors at high schools to ease the worsening shortage of high-skilled workers at d...
Korea United Pharm signs contract to supply medicines to Saudi Arabia
Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...
S.Korean companies in renewed push for Kosdaq listings
South Korean companies are making renewed pushes to go public this year even at the expense of reduced IPO values.Zaram Technology Inc., a chip desi...
Daewoong, Onchorus to undertake research on mRNA anticancer drugs
Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...
Celltrion acquires approval to sell Vegzelma in Canada
South Korea's biosimilar heavyweight Celltrion Inc. has obtained permission from the Canadian health ministry to sell anticancer biosimilar Vegzelma...
Medicox, Oramed sign MOU to enlist more institutional investors
South Korea's biomedicine firm Medicox Co. said on Monday that it had signed a strategic memorandum of understanding (MOU) with Oramed Pharmaceutica...
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Moderna to stay ahead in mRNA technology: CSO Melissa Moore
CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...
SillaJen shares jump as exchange maintains listing, allows resumed trade
Shares in South Korea’s scandal-hit biotechnological company SillaJen Inc. soared on Thursday after the local exchange decided to maintain the...
Falling won yet to cool Koreans’ fever for overseas travel
The South Korean won has continued its decline to hit lows not seen since the 2008-09 global financial crisis on sustained concerns of an economic d...
Steelmaker Husteel's operating profit skyrockets 579% in first half
Shares of Husteel, the only public company within the golf course giant Shinan Group, have doubled in price in the last three months. Industry ...
Ukraine war gives North Korea reasons to draw closer to Russia
SEOUL—Russia’s invasion of Ukraine has created an opportunity for North Korea, which has strengthened its ties with Moscow and beco...
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
Samsung Bioepis posts $1.26 billion in global biosimilar sales
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said on Friday that sales of its five biosimilar products in global markets, excludi...
Pipeline software solutions provider Cloa wins $5.1 mn in additional funding
NAVER Corp.’s startup accelerator D2SF (D2 Startup Factory) has made an additional investment into data pipeline solutions provider Cloa, the ...
